CD-CHEX CD103 Trademark

Trademark Overview

On Thursday, February 26, 2015, a trademark application was filed for CD-CHEX CD103 with the United States Patent and Trademark Office. The USPTO has given the CD-CHEX CD103 trademark a serial number of 86546889. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Friday, May 5, 2017. This trademark is owned by Streck, Inc.. The CD-CHEX CD103 trademark is filed in the Pharmaceutical Products category with the following description:

Procedural controls in the nature of chemical reagents for medical and veterinary purposes, namely, stable white blood cell reference control for use in immunophenotyping by flow cytometry
cd-chex cd103

General Information

Serial Number86546889
Word MarkCD-CHEX CD103
Filing DateThursday, February 26, 2015
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateFriday, May 5, 2017
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 21, 2015

Trademark Statements

Disclaimer with Predetermined Text"CD103"
Goods and ServicesProcedural controls in the nature of chemical reagents for medical and veterinary purposes, namely, stable white blood cell reference control for use in immunophenotyping by flow cytometry

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, March 11, 2015
Primary Code005
First Use Anywhere DateWednesday, April 1, 2015
First Use In Commerce DateMonday, May 18, 2015

Trademark Owner History

Party NameStreck, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLa Vista, NE 68128
Party NameStreck, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLa Vista, NE 68128

Trademark Events

Event DateEvent Description
Friday, May 5, 2017ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Friday, May 5, 2017ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, October 7, 2016NOTIFICATION OF FINAL REFUSAL EMAILED
Friday, October 7, 2016FINAL REFUSAL E-MAILED
Friday, October 7, 2016SU - FINAL REFUSAL - WRITTEN
Friday, September 16, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, September 16, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, September 8, 2016ASSIGNED TO LIE
Thursday, September 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, April 25, 2016NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, April 25, 2016NON-FINAL ACTION E-MAILED
Monday, April 25, 2016SU - NON-FINAL ACTION - WRITTEN
Friday, April 1, 2016STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 25, 2016USE AMENDMENT FILED
Thursday, March 31, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 25, 2016TEAS STATEMENT OF USE RECEIVED
Tuesday, September 15, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 21, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 21, 2015PUBLISHED FOR OPPOSITION
Wednesday, July 1, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, June 17, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 17, 2015ASSIGNED TO LIE
Friday, May 29, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 29, 2015EXAMINER'S AMENDMENT ENTERED
Friday, May 29, 2015NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Friday, May 29, 2015EXAMINERS AMENDMENT E-MAILED
Friday, May 29, 2015EXAMINERS AMENDMENT -WRITTEN
Thursday, May 28, 2015ASSIGNED TO EXAMINER
Wednesday, March 11, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, March 2, 2015NEW APPLICATION ENTERED IN TRAM

Related Keywords

chex cell blood white reference control cytometry flow immunophenotyping stable namely